You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
X-Ray Detectors for Synchrotron-Based Structural Biology
SBC: AREA DETECTOR SYSTEMS CORPORATION Topic: N/ADESCRIPTION (provided by applicant): Development is proposed of an x-ray Pixel Array Detector (PAD) consisting approximately of 2,000 x 2,000 pixels to enhance macromolecular crystallographic data collection at synchrotron sources. A PAD consists of an x-ray sensing integrated circuit layer bonded to a pixel electronics layer such that each pixel has its own processing electronics. PADs promise t ...
SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
A Tunable, Tabletop, Synchrotron Light Source
SBC: LYNCEAN TECHNOLOGIES, INC. Topic: N/AN/A
SBIR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
Development of Fludase for Prevention of Influenza
SBC: Nexbio, Inc. Topic: N/ADESCRIPTION (provided by applicant): Influenza is characterized by recurrent annual epidemics and periodic major worldwide pandemics. Because of the high disease-related morbidity and mortality, direct and indirect socio-economic impacts of influenza are enormous. In the last 100 years, there have been 3 major influenza pandemics. It has been about thirty years since the last pandemic. A new pand ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Prophylactic Anthrax Toxin Vaccine
SBC: VICAL, INC. Topic: N/ADESCRIPTION (provided by applicant): Vical Inc. seeks SBIR Phase II funding to develop and produce a licensable prophylactic anthrax vaccine. This project will move on an accelerated but realistic timeline with plans for human clinical trials to begin in September 2003. Although many candidate vaccines are being studied for anthrax prevention or post-exposure prophylaxis, the Vical approach has ...
STTR Phase II 2003 Department of Health and Human ServicesNational Institutes of Health -
Serum Hepcidin Immunoassay: Laboratory to Marketplace
SBC: INTRINSIC LIFESCIENCES Topic: NIDDKDESCRIPTION (provided by applicant): Disorders of iron metabolism are among the most common human diseases. During the last decade, rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders. The peptide hormonehepcidin has emerged as the master regulator of iron metabolism. Dysregulation of hepcidin is the principal or contributing factor in most syste ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
Serum Hepcidin Immunoassay: Laboratory to Marketplace
SBC: INTRINSIC LIFESCIENCES Topic: 300DESCRIPTION provided by applicant Disorders of iron metabolism are among the most common human diseases During the last decade rapid progress has been made in understanding the molecular basis of iron homeostasis and its disorders The peptide hormone hepcidin has emerged as the master regulator of iron metabolism Dysregulation of hepcidin is the principal or contributing factor in most syst ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health -
CMV Immunotherapeutic Vaccine
SBC: VICAL, INC. Topic: N/ADESCRIPTION (provided by applicant): Vical Inc. of San Diego, Ca. is the largest GMP manufacturer of plasmid DNA for vaccine clinical trials in the world. We have manufactured GMP plasmid DNA vaccines that are being used or entering clinical trials for HIV (in the US and China), malaria (up to 9 plasmids), Ebola, WNV, and SARS. Vical has undertaken an internal Product Development Program that focu ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Genome-Wide Scan for Alzheimer's Associated Genes
SBC: Perlegen Sciences, Inc. Topic: N/ADESCRIPTION (provided by applicant): The goal of this study is to identify the genetic determinants of late-onset Alzheimer's disease (AD). The proposed study uses Perlegen Sciences' high-density oligonucleotide array-based genotyping platform to genotype over 1.5 million single nucleotide polymorphisms (SNPs) across the genome in the context of a whole-genome association study of late-onset AD. ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Inhibition of hepatitis C by RNA-based therapeutics
SBC: Somagenics, Inc. Topic: N/ADESCRIPTION (provided by applicant): Treatment and prevention of hepatitis C virus (HCV) infections remains a major challenge for controlling this worldwide health problem; existing therapies are only partially effective and no vaccine is currently available. RNA interference offers the potential of a novel therapeutic approach for treating HCV infections. Toward this end, we are developing small ...
SBIR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health -
Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f
SBC: MESA TECH INTERNATIONAL, INC. Topic: NIAIDDESCRIPTION provided by applicant Rapid and accurate identification of highly infectious and pathogenic disease is extremely important for the early forecast of outbreak risk and the effective deployment of medical and administrative countermeasures Unfortunately current diagnostics for use at the point of care POC are largely immunological assays that often lack adequate sensitivity speci ...
SBIR Phase II 2014 Department of Health and Human ServicesNational Institutes of Health